Importance of interaction between nerve growth factor and α9β1 integrin in glial tumor angiogenesis

Neuro-Oncology

Volumn 14, Issue 7, 2012, Pages 890-901

  Walsh, Erin M ^a   Kim, Richard ^b   Del Valle, Luis ^c   Weaver, Michael ^b   Sheffield, Joel ^a   Lazarovici, Philip ^d   Marcinkiewicz, Cezary ^a  

^a Temple University   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

angiogenesis; disintegrins; glioma; integrins; nerve growth factor

Indexed keywords

ALPHA9 BETA1 INTEGRIN; BETA1 INTEGRIN; DISINTEGRIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY Y9A2; NERVE GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL; CAPILLARY; CELL ADHESION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; GLIOMA; HUMAN; HUMAN CELL; MICROVASCULAR ENDOTHELIAL CELL; NEOVASCULARIZATION (PATHOLOGY); PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOTAXIS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DISINTEGRINS; ENDOTHELIUM, VASCULAR; GLIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRINS; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTOR; QUAIL; VIPER VENOMS;

EID: 84862840437     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos119     Document Type: Article

References (49)

1. Contois L, Akalu A, Brooks PC. Integrins as "functional hubs" in the regulation of pathological angiogenesis. Semin Cancer Biol. 2009;19:318-328.
2. Avraamides CJ, Garmy-Susini B, Varner JA. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer. 2008;8:604-617.
3. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182-1186.
4. Kuwada SK. Drug evaluation: Volocixmab an angiogenesis-inhibiting chimeric monoclonal antibody. Curr Opin Mol Therap. 2007;9:92-98. (Pubitemid 46438452)
5. Zhank D, Pier T, McNeal DG, Wilding G, Friedl A. Effects of monoclonal anti-avb3 integrin antibody on blood vessel-a pharmacodynamic study. Invest New Drugs. 2007;25:49-55. (Pubitemid 44657642)
6. Mas-Moruno C, Rechenmacher F, Kessler H. Cilengitide: the first antiangiogenic small molecule drug candidate design, synthesis and clinical evaluationtion. Anticancer Agent Med Chem. 2010;10:753-768.
7. Senger DR, Perruzzi CA, Streit M, Koteliansky VE, de Fougerolles AR, Detmar M. The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol. 2002;160:195-204. (Pubitemid 34052280)
8. Brown MC, Staniszewska I, Del Valle L, Tuszynski GP, Marcinkiewicz C. Angiostatic activity of obtustatin as a1b1 integrin inhibitor in experimental melanoma growth. Int J Cancer. 2008;123:2195-2203.
9. Garmy-Susini B, Jin H, Zhu Y, Sung RJ, Hwang R, Varner JA. Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J Clin Invest. 2005;115:1542-1551. (Pubitemid 40814662)
10. Staniszewska I, Zaveri S, Del Valle L, Oliva I, et al. Interaction of a9b1 integrin with thrombospondin-1 promotes angiogenesis. Circ Res. 2007;100:1308-1316. (Pubitemid 46742921)
11. Ranpura V, Hapani S, Wu S. Treatment-related mortality with Bevacizumab in cancer patients. JAMA. 2011;305:487-494.
12. Eliceiri BP. Integrin and growth factor receptor crosstalk. Circ Res. 2001;89:1104-1110. (Pubitemid 34627867)
13. Porter JC, Hogg N. Integrins take partners: cross-talk between integrins and other membrane receptors. Trends Cell Biol. 1998;8:390-396. (Pubitemid 28458704)
14. Mahabeleshwar GH, Feng W, Reddy K, Plow EF, Byzova TV. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res. 2007;101:570-580. (Pubitemid 351325874)
15. Stupack GD, Cheresh DA. Integrins and angiogenesis. Curr Top Dev Biol. 2004;64:207-238. (Pubitemid 39752398)
16. Eliceiri BP, Puente XS, Hood JD, et al. Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol. 2002;157:149-160.
17. Vlahakis NE, Young BA, Atakilit A, et al. Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. J Biol Chem. 2007;282:15187-15196. (Pubitemid 47093385)
18. Staniszewska I, Sariyer IK, Lecht S, et al. The integrin a9b1 is a receptor for nerve growth factor and other neurotrophins. J Cell Sci. 2008;121:504-513. (Pubitemid 351405059)
19. Nico B, Mangieri D, Benagiano V, Crivellato E, Ribatti D. Nerve growth factor as an angiogenic factor. Microvasc Res. 2008;75:135-141. (Pubitemid 351249859)
20. Lazarovici P, Marcinkiewicz C, Lelkes PI. Cross Talk between the Cardiovascular and Nervous Systems: Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development. Curr Pharm Des. 2006;12:2609-2622.
21. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science. 1991;252:554-558. (Pubitemid 121000451)
22. Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2003;72:609-642. (Pubitemid 36930455)
23. Chao MV. The p75 neurotrophin receptor. J Neurobiol. 1994;25:1373-1385. (Pubitemid 24325063)
24. Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 2000;10:381-391. (Pubitemid 30389307)
25. Zampieri M, Chao MV. The p75 NGF receptor exposed. Science. 2004;304:833-834. (Pubitemid 38620172)
26. Bibel M, Hoppe E, Brade YA. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J. 1999;18:616-622. (Pubitemid 29057246)
27. Teng KK, Hempstead BL. Neurotrophins and their receptors: signaling trios in complex biological systems. Cell Mol LifeSci. 2004;61:35-48. (Pubitemid 38121898)
28. Werhman T, He X, Raab B, Dukipatti A, Blau H, Garcia KC. Structural and mechanistic insights into Nerve Growth Factor interactions with the TrkA and p75 receptors. Neuron. 2007;53:25-38. (Pubitemid 44969482)
29. Harrington AW, Kim JY, Yoon SO. Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. J Neurosci. 2002;22:156-166. (Pubitemid 34033493)
30. Brown MC, Staniszewska I, Lazarovici P, Tuszynski GP, Del Valle L, Marcinkiewicz C. Regulatory effect of nerve growth factor in a9b1 integrin-dependent progression of glioblastoma. Neuro-Oncol. 2008;10:968-980.
31. Bazan-Socha S, Kisiel DG, Young B, et al. Structural requirements of MLD-containing disintegrins for functional interaction with a4b1 and a9b1 integrins. Biochemistry. 2004;43:1639-1647. (Pubitemid 38200570)
32. Calvete JJ, Marcinkiewicz C, Sanz L. Snake venomics of Bitis gabonica gabonica. Protein family composition, subunit organization of venom toxins, and characterization of dimeric disintegrins bitisgabonin-1 and bitisgabonin-2. J Proteome Res. 2007;6:326-336. (Pubitemid 46173684)
33. Brown MC, Calvete JJ, Staniszewska I, Del Valle L, Lazarovici P, Marcinkiewicz C. VEGF-related protein isolated from Vipera palestinae venom, promotes angiogenesis. Growth Factors. 2007;25:108-117. (Pubitemid 47487578)
34. Pina-Oviedo S, Urbanska K, Radhakrishnan S, et al. Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy. Am J Pathol. 2007;170:1291-1304. (Pubitemid 47339336)
35. Marcinkiewicz C, Rosenthal LA, Mosser DM, Kunicki TJ, Niewiarowski S. Immunological characterization of eristostatin and echistatin binding sites on aIIbb3 and avb3 integrins. Biochem J. 1996;317:817-825.
36. Parsons-Wingerter P, Lwai B, Yang MC, et al. A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. Microvasc Res. 1998;55:201-214. (Pubitemid 28368689)
37. Cantarella G, Lempereur L, Presta M, et al. Nerve growth factorendothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J. 2002;16:1307-1309.
38. Moser KV, Reindl M, Blasig I, Humpel C. Brain capillary endothelial cells proliferate in response to NGF, express NGF receptors and secrete NGF after inflammation. Brain Res. 2004;1017:53-60. (Pubitemid 38917143)
39. Lecht S, Arien-Zakay H, Kohan M, Lelkes PI, Lazarovici P. Angiostatic effect of K252a, a Trk inhibitor in murine brain capillary endothelial cells. Mol Cell Biochem. 2010;339:201-213.
40. Lecht S, Arien-Zakay H, Wagenstein Y, et al. Transient signaling of Erk1/2, Akt and PLCgamma induced by nerve growth factor in brain capillary endothelial cells. Vascul Pharmacol. 2010;53:107-114.
41. Rahbek UL, Dissing S, Thomassen C, Hansen AJ, Tritsaris K. Nerve growth factor activates aorta endothelial cells causing PI3K/Akt-and ERK-dependentmigration. Pflugers Arch Eur J Physiol. 2005;450:355-361. (Pubitemid 41204182)
42. Dollè JP, Rezvana A, Allen FD, Lazarovici P, Lelkes PI. Nerve growth factor-induced migration of endothelial cells. J Pharmacol Exp Ther. 2005;315:1220-1227. (Pubitemid 41637838)
43. Davidson B, Reich R, Lazarovici P, et al. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clin Cancer Res. 2003;9:2248-2259. (Pubitemid 36687650)
44. Tapia V, Gabler F, Muñ oz M, et al. Tyrosine kinase A receptor (trkA): A potential marker in epithelial ovarian cancer. Gynecol Oncol. 2011;121:13-23.
45. Romon R, Adriaenssens E, Lagadec C, Germain E, Hondermarck H. Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways. Mol Cancer. 2010;9:157.
46. Oommen S, Gupta S, Vlahakis NE. Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin a9b1. J Biol Chem. 2011;286:1083-1092.
47. Mori S, Wu C-Y, Yamaji S, Seagusa J, et al. Direct binding of integrin avb3 to FGF1 plays a role in FGF1 signaling. J Biol Chem. 2008;283:18066-18075.
48. Somanath RP, Malinin NL, Byzova TV. Cooperation between integrin avb3 and VEGFR2 in angiogenesis. Angiogenesis. 2009;12:177-185.
49. Stupack GD, Cheresh DA. Apoptotic cues from the extracellular matrix: regulators of angiogenesis. Oncogene. 2003;22:9022-9029. (Pubitemid 38121702)